192 related articles for article (PubMed ID: 22952318)
1. Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice.
Kim JB; Deluna A; Mungrue IN; Vu C; Pouldar D; Civelek M; Orozco L; Wu J; Wang X; Charugundla S; Castellani LW; Rusek M; Jakubowski H; Lusis AJ
Circulation; 2012 Oct; 126(15):1896-906. PubMed ID: 22952318
[TBL] [Abstract][Full Text] [Related]
2. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
3. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
4. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.
Kuo CL; Murphy AJ; Sayers S; Li R; Yvan-Charvet L; Davis JZ; Krishnamurthy J; Liu Y; Puig O; Sharpless NE; Tall AR; Welch CL
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2483-92. PubMed ID: 21868699
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.
Wang W; Oh S; Koester M; Abramowicz S; Wang N; Tall AR; Welch CL
Circ Cardiovasc Genet; 2016 Jun; 9(3):213-22. PubMed ID: 27098250
[TBL] [Abstract][Full Text] [Related]
6. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
7. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.
Fuster JJ; Molina-Sánchez P; Jovaní D; Vinué Á; Serrano M; Andrés V
Atherosclerosis; 2012 Mar; 221(1):98-105. PubMed ID: 22226369
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
[TBL] [Abstract][Full Text] [Related]
9. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
[TBL] [Abstract][Full Text] [Related]
11. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?
Hannou SA; Wouters K; Paumelle R; Staels B
Trends Endocrinol Metab; 2015 Apr; 26(4):176-84. PubMed ID: 25744911
[TBL] [Abstract][Full Text] [Related]
12. Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.
Conway C; Beswick S; Elliott F; Chang YM; Randerson-Moor J; Harland M; Affleck P; Marsden J; Sanders DS; Boon A; Knowles MA; Bishop DT; Newton-Bishop JA
Genes Chromosomes Cancer; 2010 May; 49(5):425-38. PubMed ID: 20140953
[TBL] [Abstract][Full Text] [Related]
13. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
15. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
[TBL] [Abstract][Full Text] [Related]
16. The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications.
Tajbakhsh A; Khorrami MS; Hassanian SM; Aghasizade M; Pasdar A; Maftouh M; Tabatabai E; Parizadeh SM; Fazeli M; Ferns GA; Ghayour-Mobarhan M; Avan A
Curr Pharm Des; 2016; 22(37):5730-5737. PubMed ID: 27356775
[TBL] [Abstract][Full Text] [Related]
17. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants.
Folkersen L; Kyriakou T; Goel A; Peden J; Mälarstig A; Paulsson-Berne G; Hamsten A; Hugh Watkins ; Franco-Cereceda A; Gabrielsen A; Eriksson P;
PLoS One; 2009 Nov; 4(11):e7677. PubMed ID: 19888323
[TBL] [Abstract][Full Text] [Related]
18. p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.
González-Navarro H; Abu Nabah YN; Vinué A; Andrés-Manzano MJ; Collado M; Serrano M; Andrés V
J Am Coll Cardiol; 2010 May; 55(20):2258-68. PubMed ID: 20381282
[TBL] [Abstract][Full Text] [Related]
19. Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus.
Cunnington MS; Keavney B
Curr Atheroscler Rep; 2011 Jun; 13(3):193-201. PubMed ID: 21487702
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
